Analytik Jena's FY 2012 Revenues Climb 9 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – German analytic instrument firm Analytik Jena today said that revenues for its Fiscal Year 2012 increased 9 percent year over year.

For the fiscal year ended Sept. 30, Analytik Jena posted €94.0 million ($124.4 million) in revenues, up from €86.3 million a year ago.

Analytical Instrumentation, the company's largest segment, recorded €60.0 million in revenues, up from €53.2 million a year ago, it said in a statement, while Life Science was virtually flat at €28.2 million, compared to €28.3 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.